ArticleThe Journal of clinical and aesthetic dermatology2026
Investigating Atopic Dermatitis Prevention With Omega-3 Supplementation in Different Ethnic Populations.
Article in The Journal of clinical and aesthetic dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting approximately 5% of adults and 13% of children worldwide. Individuals with skin of color (SOC) are disproportionately affected and often experience more severe disease manifestations, including pigmentary changes and lichenification. Despite these disparities, SOC populations remain underrepresented in AD research, limiting the development of targeted prevention strategies. Emerging evidence suggests that omega-3 polyunsaturated fatty acids may play a protective role in AD through anti-inflammatory effects and support of the epidermal lipid barrier. However, the potential benefits of omega-3 supplementation in SOC populations have not been specifically examined. Global studies demonstrate significant geographic variation in omega-3 blood levels, with lower levels observed in many regions that include large SOC populations, suggesting that dietary differences may contribute to inflammatory disease risk. In addition, genetic variation in fatty acid desaturase genes influences endogenous omega-3 metabolism and may vary across ethnic groups, potentially affecting susceptibility to AD and responses to supplementation. Together, these dietary and genetic factors highlight the importance of evaluating omega-3 fatty acids as a potential preventive strategy in SOC populations. Further research examining omega-3 intake, fatty acid metabolism, and AD outcomes in diverse populations is needed to better understand their role in disease prevention and to address existing disparities in dermatologic care.
Indexed as
Identifiers
42877416PMC13668084What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.